Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junji Tanaka

Showing results (1-10 of 267) with videos related to

Pageof 27
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 1, 2003
[Target antigens for graft-versus-host disease (GVHD) and graft-versus-leukemia/tumor (GVL/T)]Junji Tanaka
Cytotherapy|February 9, 2021
Recent advances in cellular therapy for malignant lymphomaJunji Tanaka
Igaku Butsuri : Nihon Igaku Butsuri Gakkai Kikanshi = Japanese Journal of Medical Physics : an Official Journal of Japan Society of Medical Physics|May 27, 2003
[The potential patient skin injuries from radiologically guided interventional procedure: the present condition and recommendable measure]Junji Tanaka
Hematological Oncology|September 9, 2020
Recent advances in chimeric antigen receptor natural killer cell therapy for overcoming intractable hematological malignanciesJunji Tanaka
The Journal of Chemical Physics|July 23, 2004
Path integral hybrid Monte Carlo algorithm for correlated Bose fluidsShinichi Miura, Junji Tanaka
The Korean Journal of Internal Medicine|December 2, 2009
Graft-versus-leukemia effect of nonmyeloablative stem cell transplantationMasahiro Imamura, Junji Tanaka
International Journal of Hematology|November 8, 2003
Immunoregulatory cells for transplantation tolerance and graft-versus-leukemia effectMasahiro Imamura, Junji Tanaka
Blood Reviews|April 2, 2020
Recent progress in and challenges in cellular therapy using NK cells for hematological malignanciesJunji Tanaka, Jeffrey S Miller
Japanese Journal of Radiology|January 26, 2012
Cushing syndrome treated by radiofrequency ablation of adrenal gland adenomaNaoko Nishi, Junji Tanaka, Akinobu Minagawa
International Journal of Hematology|February 19, 2005
Potential role of natural killer cell receptor-expressing cells in immunotherapy for leukemiaJunji Tanaka, Masahiro Asaka, Masahiro Imamura
Pageof 27

Showing results (1-10 of 267) with videos related to

Sort By:
Pageof 27
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 1, 2003
[Target antigens for graft-versus-host disease (GVHD) and graft-versus-leukemia/tumor (GVL/T)]Junji Tanaka
Cytotherapy|February 9, 2021
Recent advances in cellular therapy for malignant lymphomaJunji Tanaka
Igaku Butsuri : Nihon Igaku Butsuri Gakkai Kikanshi = Japanese Journal of Medical Physics : an Official Journal of Japan Society of Medical Physics|May 27, 2003
[The potential patient skin injuries from radiologically guided interventional procedure: the present condition and recommendable measure]Junji Tanaka
Hematological Oncology|September 9, 2020
Recent advances in chimeric antigen receptor natural killer cell therapy for overcoming intractable hematological malignanciesJunji Tanaka
The Journal of Chemical Physics|July 23, 2004
Path integral hybrid Monte Carlo algorithm for correlated Bose fluidsShinichi Miura, Junji Tanaka
The Korean Journal of Internal Medicine|December 2, 2009
Graft-versus-leukemia effect of nonmyeloablative stem cell transplantationMasahiro Imamura, Junji Tanaka
International Journal of Hematology|November 8, 2003
Immunoregulatory cells for transplantation tolerance and graft-versus-leukemia effectMasahiro Imamura, Junji Tanaka
Blood Reviews|April 2, 2020
Recent progress in and challenges in cellular therapy using NK cells for hematological malignanciesJunji Tanaka, Jeffrey S Miller
Japanese Journal of Radiology|January 26, 2012
Cushing syndrome treated by radiofrequency ablation of adrenal gland adenomaNaoko Nishi, Junji Tanaka, Akinobu Minagawa
International Journal of Hematology|February 19, 2005
Potential role of natural killer cell receptor-expressing cells in immunotherapy for leukemiaJunji Tanaka, Masahiro Asaka, Masahiro Imamura
Pageof 27